A detailed history of Wolverine Trading, LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 790 shares of MEDP stock, worth $275,299. This represents 0.0% of its overall portfolio holdings.

Number of Shares
790
Previous 704 12.22%
Holding current value
$275,299
Previous $289,000 9.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$320.58 - $457.29 $27,569 - $39,326
86 Added 12.22%
790 $263,000
Q2 2024

Aug 14, 2024

BUY
$372.0 - $424.34 $261,888 - $298,735
704 New
704 $289,000
Q4 2023

Feb 14, 2024

BUY
$227.52 - $312.68 $1.06 Million - $1.46 Million
4,677 New
4,677 $1.43 Million
Q1 2022

May 16, 2022

SELL
$138.87 - $214.31 $261,075 - $402,902
-1,880 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$182.74 - $227.9 $127,004 - $158,390
695 Added 58.65%
1,880 $412,000
Q3 2021

Nov 12, 2021

BUY
$170.18 - $198.21 $201,663 - $234,878
1,185 New
1,185 $222,000
Q1 2021

May 14, 2021

SELL
$132.02 - $168.26 $330,974 - $421,827
-2,507 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$109.38 - $149.19 $166,913 - $227,663
-1,526 Reduced 37.84%
2,507 $346,000
Q4 2019

Feb 12, 2020

SELL
$70.08 - $84.64 $2,592 - $3,131
-37 Reduced 0.91%
4,033 $336,000
Q2 2019

Aug 20, 2019

SELL
$53.64 - $65.42 $36,957 - $45,074
-689 Reduced 14.48%
4,070 $266,000
Q4 2018

Feb 14, 2019

SELL
$46.97 - $63.98 $972,889 - $1.33 Million
-20,713 Reduced 81.32%
4,759 $246,000
Q3 2018

Nov 14, 2018

BUY
$43.25 - $63.74 $709,992 - $1.05 Million
16,416 Added 181.27%
25,472 $1.53 Million
Q1 2018

May 15, 2018

BUY
$32.03 - $39.05 $290,063 - $353,636
9,056 New
9,056 $316,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.8B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.